Association of Monocyte Count and Monocyte/Lymphocyte Ratio with the Risk of Cardiovascular Outcomes in Patients with CKD.
Ester S OhZhiying YouKristen L NowakAnna J JovanovichPublished in: Kidney360 (2022)
These results suggest that monocyte count and MLR may have the potential to be cost-effective, clinically available indicators of CVD risk in the CKD population.